Expression of blood group antigens in bladder cancer: current concepts

Semin Surg Oncol. 1992 Sep-Oct;8(5):308-15. doi: 10.1002/ssu.2980080510.

Abstract

Blood group antigens are a group of carbohydrate structures bound to membrane lipids or proteins of erythrocytes and certain epithelial tissues including urothelium. The Lewis antigens are structures that are genetically and biochemically related to the ABO blood group. The ABO and Lewis blood group systems are differentially expressed in the normal urothelium of "secretors" versus "nonsector" individuals. The normal urothelium of "secretors" is rich ABH, Leb, and Ley antigens while the urothelium of "nonsecretors" does not express these antigens. Therefore, deletion of ABH antigens, commonly noted in TCC, can only be reliably ascertained in "secretor" individuals. Neoexpression of the Lewis X antigen (which is absent in normal urothelium) is noted in over 85% of TCC regardless of tumor stage and grade. Immunocytological detection of the Lewis X antigen on exfoliated bladder epithelial cells enhances the detection of urothelial tumor cells, particularly from low grade and low stage neoplasms.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • ABO Blood-Group System / genetics
  • ABO Blood-Group System / immunology*
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Lewis Blood Group Antigens / genetics
  • Lewis Blood Group Antigens / immunology*
  • Neoplasm Staging
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / immunology*
  • Urinary Bladder Neoplasms / pathology

Substances

  • ABO Blood-Group System
  • Lewis Blood Group Antigens